Intratumoral but not peritumoral lymphatic vessel density measured by D2-40 expression predicts poor outcome in gastric cancer - Roc curve analysis to find cut-off point

Anticancer Research

Volumn 34, Issue 6, 2014, Pages 3113-3118

  Donizy, Piotr ^a   Rudno Rudzinska, Julia ^b   Halon, Agnieszka ^a   Dziegala, Mateusz ^a   Kabarowski, Jedrzej ^a   Frejlich, Ewelina ^b   Dziegiel, Piotr ^c,d   Kielan, Wojciech ^b   Matkowski, Rafal ^a,e  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b Second Department of General and Oncological Surgery   (Poland)

^c Department of Histology and Embryology ^*  (Poland)

^d UNIVERSITY OF WROC AW   (Poland)

^e Dolnoslaskie Centrum Onkologii Wroclaw   (Poland)

Author keywords

D2 40; Gastric cancer; Immunohistochemistry; Podoplanin; Prognostic marker

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; FORMALDEHYDE; MONOCLONAL ANTIBODY D2-40; PODOPLANIN; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; PDPN PROTEIN, HUMAN; TUMOR MARKER;

ADULT; ARTICLE; BLOOD VESSEL PARAMETERS; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; DECISION MAKING; DISTANT METASTASIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFLAMMATION; LYMPH NODE METASTASIS; LYMPHANGIOGENESIS; LYMPHATIC VESSEL DENSITY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIMARY TUMOR; PROTEIN EXPRESSION; RECEIVER OPERATING CHARACTERISTIC; RECURRENCE FREE SURVIVAL; STOMACH CANCER; TUMOR INVASION; ULCER; ADENOCARCINOMA; CANCER GRADING; CANCER STAGING; D2-40; FOLLOW UP; IMMUNOLOGY; LYMPH VESSEL; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; PROGNOSTIC MARKER; STOMACH TUMOR; SURVIVAL RATE;

D2-40; GASTRIC CANCER; IMMUNOHISTOCHEMISTRY; PODOPLANIN; PROGNOSTIC MARKER;

ADENOCARCINOMA; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHANGIOGENESIS; LYMPHATIC VESSELS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PROGNOSIS; ROC CURVE; STOMACH NEOPLASMS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84906309108     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Duff SE, Li C, Jeziorska M, Kumar S, Saunders MP, Sherlock D, O'Dwyer ST and Jayson GC: Vascular endothelial growth factors C and D and lymphangiogenesis in gastrointestinal tract malignancy. Br J Cancer 89: 426-430, 2003.
2. Kim JH, Park SS, Park SH, Kim SJ, Mok YJ, Kim CS, Lee JH and Kim YS: Clinical significance of immunohistochemically-identified lymphatic and/or blood vessel tumor invasion in gastric cancer. J Surg Res 162: 177-183, 2010.
3. Sleeman JP and Thiele W: Tumor metastasis and the lymphatic vasculature. Int J Cancer 125: 2747-2756, 2009.
4. Yonemura Y, Endou Y, Tabachi K, Kawamura T, Yun HY, Kameya T, Hayashi I, Bandou E, Sasaki T and Miura M: Evaluation of lymphatic invasion in primary gastric cancer by a new monoclonal antibody, D2-40. Hum Pathol 37: 1193-1199, 2006.
5. Kuroda N, Tanida N, Oonishi K, Inoue K, Ohara M, Mizuno K, Taguchi T, Hayashi Y, Hanazaki K and Lee GH: Significance of D2-40 expression in the diagnosis of gastrointestinal stromal tumor. Med Mol Morphol 41: 109-112, 2008.
6. Miyahara M, Tanuma J, Sugihara K and Semba I: Tumor lymphangiogenesis correlates with lymph node metastasis and clinicopathologic parameters in oral squamous cell carcinoma. Cancer 110: 1287-1294, 2007.
7. Wicki A and Christofori G: The potential role of podoplanin in tumour invasion. Br J Cancer 96: 1-5, 2007.
8. De Sousa SF, Gleber-Netto FO, De Oliveira-Neto HH, Batista AC, Nogueira Guimarães Abreu MH and De Aguiar MC: Lymphangiogenesis and podoplanin expression in oral squamous cell carcinoma and the associated lymph nodes. Appl Immunohistochem Mol Morphol 20: 588-594, 2012.
9. Imamura Y, Watanabe M, Nagai Y, Baba Y, Hirashima K, Karashima R, Iwatsuki M, Yoshida N, Kinoshita K, Kurashige J, Iyama K and Baba H: Lymphatic vessel invasion detected by the D2-40 monoclonal antibody is an independent prognostic factor in node-negative esophageal squamous cell carcinoma. J Surg Oncol 105: 277-283, 2012.
10. Tong L, Yuan S, Feng F and Zhang H: Role of podoplanin expression in esophageal squamous cell carcinoma: a retrospective study. Dis Esophagus 25: 72-80, 2012.
11. Sobin LH and Wittekind C: TNM Classification of Malignant Tumors, Fifth Edition. Wiley-Liss, New York, N Y, USA, 1997.
12. Weidner N, Semple J, Welich W and Folkman J: Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. New Eng J Med 324: 1-8, 1991.
13. Rudno-Rudzinska J, Kielan W, Grzebieniak Z, Dziegiel P, Donizy P, Mazur G, Knakiewicz M, Frejlich E and Halon A: High density of peritumoral lymphatic vessels measured by D2-40/podoplanin and LYVE-1 expression in gastric cancer patients: an excellent prognostic indicator or a false friend? Gastric Cancer 16: 513-520, 2013.
14. Hałon A, Donizy P, Biecek P, Rudno-Rudzinska J, Kielan W and Matkowski R: HER-2 expression in immunohistochemistry has no prognostic significance in gastric cancer patients. Sci World J: ID: 941259, 2012.
15. Martin-Villar E, Scholl FG, Gamallo C, Yurrita MM, Munoz-Guerra M, Cruces J and Quintanilla M: Characterization of human PA2.26 antigen (T1alpha-2, podoplanin), a small membrane mucin induced in oral squamous cell carcinomas. Int J Cancer 113: 899-910, 2005.
16. Schacht V, Dadras SS, Johnson LA, Jackson DG, Hong YK and Detmar M: Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors. Am J Pathol 166: 913-921, 2005.
17. Kato Y, Kaneko M, Sata M, Fujita N, Tsuruo T and Osawa M: Enhanced expression of aggrus (T1alpha/podoplanin), a platelet-aggregation-inducing factor in lung squamous cell carcinoma. Tumour Biol 26: 195-200, 2005.
18. Kimura N and Kimura I: Podoplanin as a marker for mesothelioma. Pathol Int 55: 83-86, 2005.
19. Martin-Villar E, Megias D, Castel S, Yurrita MM, Vilaro S and Quintanilla M: Podoplanin binds ERM proteins to activate RhoA and promote epithelial-mesenchymal transition. J Cell Sci 119: 4541-4553, 2006.
20. Wicki A, Lehembre F, Wick N, Hantusch B, Kerjaschki D and Christofori G: Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton. Cancer Cell 9: 261-272, 2006.
21. Fernandez-Munoz B, Yurrita MM, Martin-Villar E, Carrasco-Ramirez P, Megias D, Renart J and Quintanilla M: The transmembrane domain of podoplanin is required for its association with lipid rafts and the induction of epithelial-mesenchymal transition. Int J Biochem Cell Biol 43: 886-896, 2011.
22. Nakamura Y, Yasuoka H, Tsujimoto M, Kurozumi K, Nakahara M, Nakao K and Kakudo K: Importance of lymph vessels in gastric cancer: a prognostic indicator in general and a predictor for lymph nodemetastasis in early-stage cancer. J Clin Pathol 59: 77-82, 2006.
23. Coskun U, Akyurek N, Dursun A and Yamac D: Peritumoral lymphatic microvessel density associated with tumor progression and poor prognosis in gastric carcinoma. J Surg Res 164: 110-115, 2009.
24. Yu JW, Wu JG, Tajima Y, Li XQ, Du GY, Zheng LH, Zhang B, Ni XC and Jiang BJ: Study on lymph node metastasis correlated to lymphangiogenesis, lymphatic vessel invasion, and lymph node micrometastasis in gastric cancer. J Surg Res 168: 188-196, 2011.
25. Lee K, Park do J, Choe G, Kim HH, Kim WH and Lee HS: Increased intratumoral lymphatic vessel density correlates with lymph node metastasis in early gastric carcinoma. Ann Surg Oncol 17: 73-80, 2010.
26. Wang XL, Fang JP, Tang RY and Chen XM: Different significance between intratumoral and peritumoral lymphatic vessel density in gastric cancer: a retrospective study of 123 cases. BMC Cancer 10: 299, 2010.